Measurable Residual Disease Testing
March 4, 2024
Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.
Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.
I found out last week that I am not only in a complete remission, but also there was no measurable CLL in my peripheral blood done by flow cytometry, down to 1 in 10,000 cells
A newly published paper in JAMA Oncology found that among cancer patients with suspected ibrutinib-related cardiotoxic effects, the presence of heart muscle injury and scarring is high, and this is associated with an increased risk of developing future cardiovascular adverse events.
Dr. Ed Ratner’s Review of For Blood and Money by Nathan Vardi that chronicles the development of two blockbuster drugs
Over the course of a year of monthly meetings, the CLL Bloodline will teach the BASICS needed to understand CLL, bring news, help with the acronyms and new vocabulary, and offer
Over the course of a year of monthly meetings, the CLL Bloodline will teach the BASICS needed to understand CLL, bring news, help with the acronyms and new vocabulary, and offer
The use of CT scans is an effective diagnostic method to assess internal organs and disease status, as well as the effect of treatment in cancer patients. CT scans, with or
CLL / SLL Testing & Imaging There are multiple types of blood tests that you may encounter during your CLL journey. For the newly diagnosed, getting the appropriate testing and knowing
Glossary: Blood (Hematology) Tests In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered